Combination therapy for a pregnant woman with severe refractory ITP.
Orisaka
Makoto
M
Shukunami
Ken-Ichi
K
Orisaka
Sanae
S
Goto
Kenji
K
Yoshida
Yoshio
Y
Kotsuji
Fumikazu
F
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010298:Parity; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D003613:Danazol